Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT01835132
Brief Title:
Gevokizumab for Active Scleritis
Official Title:
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)
Study:
NCT01835132
Protocol Section:
NCT01835132